Literature DB >> 8933989

Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene.

D R Nyholt1, R P Curtain, P T Gaffney, P Brimage, P J Goadsby, L R Griffiths.   

Abstract

5-Hydroxytryptamine (5HT), commonly known as serotonin, which predominantly serves as an inhibitory neurotransmitter in the brain, has long been implicated in migraine pathophysiology. This study tested an MspI polymorphism in the human 5HT2A receptor gene (HTR2A) and a closely linked microsatellite marker (D13S126), for linkage and association with common migraine. In the association analyses, no significant differences were found between the migraine and control populations for both the MspI polymorphism and the D13S126 microsatellite marker. The linkage studies involving three families comprising 36 affected members were analysed using both parametric (FASTLINK) and non-parametric (MFLINK and APM) techniques. Significant close linkage was indicated between the MspI polymorphism and the D13S126 microsatellite marker at a recombination fraction (theta) of zero (lod score = 7.15). Linkage results for the MspI polymorphism were not very informative in the three families, producing maximum and minimum lod scores of only 0.35 and -0.39 at recombination fractions (theta) of 0.2 and 0.00, respectively. However, linkage analysis between the D13S126 marker and migraine indicated significant non-linkage (lod < -2) up to a recombination fraction (theta) of 0.028. Results from this study exclude the HTR2A gene, which has been localized to chromosome 13q14-q21, for involvement with common migraine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933989     DOI: 10.1046/j.1468-2982.1996.1607463.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

1.  A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach.

Authors:  Matthew P Johnson; Lyn R Griffiths
Journal:  J Hum Genet       Date:  2005-10-01       Impact factor: 3.172

2.  Searching for migraine genes: exclusion of 290 cM out of the whole human genome.

Authors:  L Monari; M Mochi; M L Valentino; C Arnaldi; P Cortelli; A De Monte; G Pierangeli; G Prologo; C Scapoli; S Soriani; P Montagna
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 3.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

4.  MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.

Authors:  Masakazu Ishii; Shunichi Shimizu; Yuki Sakairi; Ayumu Nagamine; Yuika Naito; Yukiko Hosaka; Yuko Naito; Tatsuya Kurihara; Tomomi Onaya; Hideto Oyamada; Atsuko Imagawa; Kenji Shida; Johji Takahashi; Katsuji Oguchi; Yutaka Masuda; Hajime Hara; Shino Usami; Yuji Kiuchi
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

5.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

Review 6.  Update on the genetics of migraine.

Authors:  Miguel Estevez; Kathy L Gardner
Journal:  Hum Genet       Date:  2003-11-18       Impact factor: 4.132

7.  Common genetic risk factors for psychiatric and simatic disorders.

Authors:  Brigitta Bondy
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

8.  The primary headaches: genetics, epigenetics and a behavioural genetic model.

Authors:  Pasquale Montagna
Journal:  J Headache Pain       Date:  2008-03-15       Impact factor: 7.277

9.  Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology.

Authors:  Ti Li; Shupeng Guo; Meixi Lu; Fang Lu; Tianjiao Lu; Chunze Zheng
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.